N1,N1'-([1,1'-Biphenyl]-4,4'-diyl)bis(N1-methylbenzene-1,4-diamine)

Catalog No. :
ACTAZX041
CAS No. :
1018982-21-2
Molecular Formula :
C26H26N4
Molecular Weight :
394.52

IUPAC Name:N1,N1'-([1,1'-biphenyl]-4,4'-diyl)bis(N1-methylbenzene-1,4-diamine)

N1,N1'-([1,1'-Biphenyl]-4,4'-diyl)bis(N1-methylbenzene-1,4-diamine) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg97%$412.00Login to see priceInquiryInquiry
50mg97%$700.00Login to see priceInquiryInquiry
100mg97%$1188.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN1,N1'-([1,1'-Biphenyl]-4,4'-diyl)bis(N1-methylbenzene-1,4-diamine)
IUPAC NameN1,N1'-([1,1'-biphenyl]-4,4'-diyl)bis(N1-methylbenzene-1,4-diamine)
Molecular FormulaC26H26N4
Molecular Weight394.52
SMILESCN(C1=CC=C(N)C=C1)C1=CC=C(C2=CC=C(N(C)C3=CC=C(N)C=C3)C=C2)C=C1
InChI KeyUHIXFUMVHZAVGP-UHFFFAOYSA-N
Synonym[1,1'-Biphenyl]-4,4'-diamine, N4,N4'-bis(4-aminophenyl)-N4,N4'-dimethyl-;1,1'-Biphenyl]-4,4'-diamine, N4,N4'-bis(4-aminophenyl)-N4,N4'-dimethyl-;N1,N1'-([1,1'-Biphenyl]-4,4'-diyl)bis(N1-methylbenzene-1,4-diamine);1-N-(4-{4-[(4-aminophenyl)(methyl)amino]phenyl}phenyl)-1-N-methylbenzene-1,4-diamine - [AC80081]
CAS No.1018982-21-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTAZX041 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTAZX041 route product structure diagram
    ACTAZX0411018982-21-2
Inquiry

2. ACTAZX041 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTAZX041 route product structure diagram
    ACTAZX0411018982-21-2
Inquiry

Comments (0)